N4 Pharma Plc (LON:N4P – Get Free Report)’s share price hit a new 52-week low during mid-day trading on Thursday . The company traded as low as GBX 0.60 ($0.01) and last traded at GBX 0.70 ($0.01), with a volume of 1668891 shares trading hands. The stock had previously closed at GBX 0.68 ($0.01).
N4 Pharma Stock Performance
The stock’s 50-day moving average price is GBX 0.77 and its 200-day moving average price is GBX 0.90. The company has a market cap of £1.88 million, a P/E ratio of -120.00 and a beta of -0.06. The company has a debt-to-equity ratio of 1.62, a current ratio of 27.88 and a quick ratio of 7.28.
N4 Pharma Company Profile
N4 Pharma Plc, a specialist pharmaceutical company, develops silica nanoparticle delivery system for pharmaceutical and biotechnology companies in the United Kingdom. It develops Nuvec, a non-viral adjuvant delivery system for vaccines and cancer treatments. N4 Pharma Plc was incorporated in 1979 and is based in London, the United Kingdom.
Recommended Stories
- Five stocks we like better than N4 Pharma
- How to Invest in Insurance Companies: A Guide
- 3 Value Stocks Too Small For Buffett’s Portfolio
- Dividend Payout Ratio Calculator
- Foot Locker Builds Up Another Head of Steam; Gains Imminent
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Disney Stock Catches 3 Upgrades In a Single Week
Receive News & Ratings for N4 Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for N4 Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
